Clinical Experience in Managing Pediatric Patients with Ultra-short Bowel Syndrome using Omega-3 Fatty Acid

Abstract

Total parenteral nutrition (TPN) remains an important component of the management of short bowl syndrome in pediatric patients. However, prolonged TPN is known to be associated with cholestasis. Recently, the use of omega-3-fatty acid (Omegaven) has been proposed to improve TPN cholestasis. We present the early outcome after administration of Omegaven in four patients with ultra-short bowel syndrome. Based on our experience, it appears that omega-3 fatty acid can reverse and prevent the advent of TPN-related cholestasis, thereby significantly improving the process of intestinal adaptation. We suggest that clinicians consider this treatment option before proceeding to invasive surgery to reverse cholestasis. Prospective randomized trials are necessary to define a standard protocol and elucidate other potential benefits of this novel agent.

References

• 1 Beath SV, Davies P, Papadopoulou A. et al . Parenteral nutrition-related cholestasis n postsurgical neonates: Multivariate analysis of risk factors.  J Pediatr Surg. 1996;  31 ((4)) 604-606
• 2 Gura KM, Duggan CP, Collier SB. et al . Reversal of parenteral nutrition-associated liver disease in two infants with short bowel syndrome using parenteral fish oil: Implication for future management.  Pediatr. 2006;  118 ((1)) 197-201
• 3 Ekema G, Falchetti D, Boroni G. et al . Reversal of severe parenteral nutrition-associated liver disease in an infant with short bowel syndrome using parenteral fish oil (Omega-3 fatty acids).  J Pediatr Surg. 2008;  43 1191-1195
• 4 Wessel JJ, Kocoshis SA. Nutritional management of infants with short bowel syndrome.  Semin Perinatol. 2007;  31 104-111
• 5 Vernon AH, Georgeson KE. Surgical options for short bowel syndrome.  Semin Pediatr Surg. 2001;  10 ((2)) 91-98
• 6 Reyes J. Intestinal transplantation for children with short bowel syndrome.  Semin Pediatr Surg. 2001;  10 99
• 7 Wong KKY, Lan LCL, Lin SCL. et al . Mucous fistula refeeding in premature neonates with enterostomies.  J Pediatr Gastroenterol Nutr. 2004;  39 43-45
• 8 Richardson L, Banerjee S, Rabe H. What is the evidence on the practice of mucous fistula refeeding in neonates with short bowel syndrome?.  J Pediatr Gastroenterol Nutr. 2006;  43 ((2)) 267-270
• 9 Gura KM, Lee S, Valim C. et al . Safely and efficacy of a fish-oil-based fat emulsion in the treatment of parenteral nutrition-associated liver disease.  Pediatrics. 2008;  121 678-686
• 10 Van Aerde JE, Duerksen DR, Gramlich L. et al . Intravenous fish oil emulsion attenuates total parenteral nutrition-induced cholestasis in newborn piglets.  Pediatr Res. 1999;  45 202-208
• 11 Heller AR, Rossler S, Litz RJ. et al . Omega-3 fatty acids improve the diagnosis-related clinical outcome.  Crit Care Med. 2006;  34 972-979

Correspondence